ATAI
Sign in
ATAI Life Sciences BV
Save
221.50M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Atai Life Sciences N. V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders.
Similar securities
Based on sector and market capitalization
Report issue